ALB and metastatic malignant neoplasm: Another prediction tool called Index4 is calculated based on only four parameters, including the Eastern Co-operative Oncology Group (ECOG) performance status of the patient, low serum albumin, renal insufficiency and the presence of a metastatic cancer [18].